BioSpace News Archive

The data is continuing to come in on the various COVID-19 variants, and so far the news is pretty good.

Senior White House adviser Andy Slavitt said the administration is striving to meet its goal of ensuring enough vaccine supply by summer, but acknowledged there could be some hurdles that will prevent that timeline.

While the ATLAS platform has the potential to lead to an effective vaccine in itself, its greatest impact in the field of immunotherapy may be that it offers a new way of understanding how a tumor evades the therapy’s boundaries by identifying bad Inhibigens that lead to suppressive, or inhibitory, responses.

Today marked some wheeling and dealing in the life sciences industry as several companies licensed products or invested in other companies. Here’s a look.

The FDA is on a roll granting approvals. Three companies announced IND updates today.

A research team from Brigham and Women’s Hospital has discovered an astrocyte sub-population that serves an anti-inflammatory function in the brain based on signals regulated by gut bacteria.

A special fund for vaccine research that was set aside by the U.S. Department of Health and Human Services in 2010 has been misused to pay for unrelated expenses, a government report shows.

The U.S. Department of Justice is set to recover more than $3 billion this year from pharmaceutical and medical device manufacturers as well as healthcare providers, labs and pharmacies found guilty of healthcare fraud under the False Claims Act.

Regulators removed samples and records from the plant, which are being examined by experts from Belgium, the Netherlands, Italy, and Spain.

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.